Braveheart Bio
Transforming Hypertrophic Cardiomyopathy Care
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life science investors including A…


